Table 5. Acute and chronic comorbidities in patients with community-acquired compared to nosocomial-acquired pneumonia caused by Pseudomonas aeruginosa.
Organ systems | Acute and chronic comorbidities | Community-acquired pneumonia (n = 91) (%) | Nosocomial-acquired pneumonia (n = 77) (%) | P value |
---|---|---|---|---|
Cardiovascular diseases | Acute comorbidities | |||
Anemia | 19 (20.9) | 8 (10.4) | 0.102 | |
Cardiac arrhythmia | 23 (25.3) | 28 (36.4) | 0.165 | |
Myocardial infarction | 7 (7.7) | 9 (11.7) | 0.538 | |
Sepsis | 8 (8.8) | 19 (24.7) | 0.010 | |
Shock | 4 (4.4) | 8 (10.4) | 0.229 | |
Chronic comorbidities | ||||
Coronary artery disease | 20 (22.0) | 33 (42.9) | 0.006 | |
Hypertension | 37 (40.7) | 37 (48.1) | 0.420 | |
Peripheral arterial occlusive disease | 5 ((5.5) | 12 (15.6) | 0.057 | |
Valvular heart disease | 11 (12.1) | 18 (23.4) | 0.085 | |
Pulmonary diseases | Acute comorbidities | |||
Acute respiratory failure | 13 (14.3) | 13 (16.9) | 0.807 | |
Exacerbation by chronic obstructive pulmonary disease | 16 (17.6) | 2 (2.6) | 0.004 | |
Pleural effusion | 2 (2.2) | 10 (13.0) | 0.016 | |
Chronic comorbidities | ||||
Chronic obstructive pulmonary disease | 39 (42.9) | 13 (16.9) | 0.0005 | |
Cor pulmonale | 10 (11.0) | 5 (6.5) | 0.454 | |
Gastrointestinal diseases | Chronic comorbidities | |||
Diabetes | 22 (24.2) | 17 (22.1) | 0.888 | |
Hyperlipidemia | 3 (3.3) | 8 (10.4) | 0.124 | |
Obesity | 3 (3.3) | 9 (11.7) | 0.071 | |
Percutaneous endoscopic gastrostomy | 11(12.1) | 3 (3.9) | 0.102 | |
Kidney diseases | Acute comorbidities | |||
Acute renal failure | 7 (7.7) | 15 (19.5) | 0.043 | |
Acute urinary tract infection | 13 (14.3) | 6 (7.8) | 0.279 | |
Electrolyte imbalance | 10 (11.0) | 6 (7.8) | 0.663 | |
Chronic comorbidities | ||||
Chronic renal failure | 10 (11.0) | 16 (20.8) | 0.125 | |
Neurology diseases | Chronic comorbidities | |||
Epilepsy | 10 (11.0) | 10 (13.0) | 0.863 | |
State after stroke | 11 (12.1) | 7 (9.1) | 0.708 |